In this week's episode of the Everything Epigenetics podcast, Dr. Chiara Herzog and I talk about how epigenetics is making waves in the medical world and how it could change treatment. Translational scientist and research fellow Dr. Herzog provides insights from her role in the Biomarkers of Aging Consortium and her work on the TirolGESUND project, one of the largest multi-omic human lifestyle intervention trials to date. We investigate the potential applications of epigenetics in cancer detection, aging biomarkers, and preventive measures that could change the paradigm of healthcare from one that is reactive to one that is proactive. We also explore the fascinating potential of using epigenetic markers to anticipate disease before it manifests itself, particularly in the context of cancer research, and how this could impact the delivery of tailored healthcare.
You'll learn about:
Chapters:
00:00 Welcome and introduction
02:30 Dr. Herzog’s journey from neuroscience to epigenetics
05:40 Recent breakthroughs in epigenetic research
12:10 Epigenetics and cancer risk: promising findings
19:15 TirolGESUND study: setup, interventions, and what to expect
27:40 Why studying different cell types matters in epigenetics
32:00 Understanding the exposome and its impact on health
38:20 Future steps for advancing epigenetic biomarkers in healthcare
45:00 Exciting upcoming projects in epigenetics research
Where to Find Us:
Instagram
Follow us on:
Apple Podcast
Visit our website for more information and resources: everythingepigenetics.com
Thank you for joining us at the Everything Epigenetics Podcast and remember you have control over your Epigenetics, so tune in next time to learn more about how to harness this knowledge for your benefit.